Cardinal Health Inc. (CAH)
Defense IPO Leads Five Stocks To Watch As Iran War Pressures Market
Defense plays Karman Holdings and General Dynamics are among five stocks to watch as the Iran war drives stock market action.
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
CAH's Pharmaceutical and Specialty Solutions segment surged in fiscal Q2'26 with 19% revenue growth to $61B, fueled by specialty drugs, GLP-1 demand and generics momentum.
Can Specialty Momentum Push CAH's Earnings Growth Beyond 25% in FY26?
CAH expects specialty revenues to top $50B in FY26 as its expanding MSO and biopharma services ecosystem helps drive projected EPS growth of 23-26%.
Cardinal Health, Inc. (CAH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at Leerink Global Healthcare Conference 2026 Transcript
Cardinal Health, Inc. (CAH) Presents at Leerink Global Healthcare Conference 2026 Transcript
Why Cardinal Health May Be a Best Buy for the Coming Stagflation
This morning's jobs report landed hard.
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
CAH shares have surged 49% in six months as strong pharma distribution, expanding specialty services and fast-growing adjacencies fuel Cardinal Health???s earnings outlook.
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Q4 Earnings: These Buy-Rated Stocks Crushed Expectations
The 2025 Q4 earnings cycle keeps rolling along, with overall growth remaining strong. Specifically, these companies knocked it out of the park, with both also sporting a favorable Zacks Rank.
